Mounjaro, the breakthrough obesity and diabetes drug from Eli Lilly and Company, has become India’s highest-selling ...

US-based pharma giant Eli Lilly’s blockbuster weight-loss drug, Mounjaro, is set to expand its reach across India through a ...

Eli Lilly signed an agreement with Cipla allowing the Indian drugmaker to sell its blockbuster weight-loss drug under a separate brand in the country, the companies said on Thursday. Under the ...

According to Pharmarack, unlike the previous two years where October sales for Oral Rehydration Solutions (ORS) is lesser ...

Eli Lilly recorded ₹1 billion in Mounjaro sales in October, compared to Augmentin’s ₹800 million ・Since its March 2025 launch ...

Over 24% of Indian adults across all states are now considered overweight or obese with more than 12.5 million children under 5 battling obesity ...

Homegrown drugmaker Cipla and Eli Lilly and Company (India) on Thursday announced an agreement to distribute and promote type 2 diabetes and chronic weight management drug tirzepatide under a new ...

Danish pharma major Novo Nordisk has slashed the price of Wegovy by up to 37%, to take on its key rival Eli Lilly. Here's how ...

US drugmaker Eli Lilly has struck a deal with domestic drug giant Cipla Ltd to widen the reach of its blockbuster weight loss drug tirzepatide, doubling down on India’s booming market ahead of an ...

Mounjaro (tirzepatide) is a prescription drug for adults with type 2 diabetes. One of the more common side effects of Mounjaro is constipation. In clinical studies, constipation was reported in 6–7% ...

Amy Schumer is looking snatched. On Thursday, the actress, 44, took to Instagram to share a mirror selfie on her Instagram Stories. The shot showed Schumer wearing a sports bra with her flat stomach ...

Like so many who have lost weight on Mounjaro, Susan Anderson is positively evangelical about the silencing of the dreaded 'food noise' that had plagued her whole life. She lost nearly 9st over 21 ...